CARE Carter Bankshares, Inc. Common Stock NATIONAL COMMERCIAL BANKS Best National Banks Stocks 2026 →

Carter Bankshares (CARE) Stock: Buy, Sell, or Hold?

$29.22
-0.26 (-0.88%) â–ŧ
5d: -0.14% 30d: -3.21% 90d: -10.59%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (91%)
Quality Score
50/100
Position
SLIGHTLY LOW
30-Day Fair Range
$29.21 – $30.56
Position: SLIGHTLY LOW
Forward P/E & Valuation
11.7x FAIR
vs 10.5x historical avg
Wall Street Target
$34.08
+16.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$28.27 / $30.22
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: CARE is fairly priced but lacks strong directional signals. At 3.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.

Get Alerted When CARE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$6.41
Based on -22.3% avg growth
INTRINSIC VALUE TODAY
$3.98
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CARE is currently trading at $29.22, which is considered slightly low relative to its 30-day fair value range of $29.21 to $30.56. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.7) compared to its historical average (10.5). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CARE is in a strong downtrend. Immediate support is located at $28.27, while resistance sits at $30.22.

Market Sentiment: CARE scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $34.08 (+16.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $29.21 - $30.56
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 91.2%

Trading Range & Key Levels

30-Day Trading Range $29.21 - $30.56
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) Âą$0.99 (3.4%)
Support Level $28.27
Resistance Level $30.22
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding CARE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (70/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($34.08)
  • NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 11.66
Wall Street Target $34.08 (+16.6%)
Revenue Growth (YoY) 0.1%
Earnings Growth (YoY) 45.8%
Profit Margin 45.7%
Valuation Premium vs History +3.5% premium
PE vs Historical 11.7 vs 10.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +3.5% (market-implied from PE analysis)
1-Year Target $30.24 (+4%)
2-Year Target $31.30 (+7%)
3-Year Target $32.40 (+11%)
3-Yr Target (if PE normalizes) (PE: 12→11) PE COMPRESSION $29.16 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -48.6%) $36.27 (+24%)
Base: (SPY PE: 11.7, Growth: -48.6%) $21.30 (-27%)
Bear: (PE: 9.9, Growth: -48.6%) $18.11 (-38%)
📈 Valuation based on Current Earnings
Trailing PE: 4.99 | Current EPS (TTM): $5.91
Bull Case $16.21 (-45%)
Analyst growth -50.0%, PE expands to 5.5
Base Case $14.74 (-50%)
Market implied -50.0%, PE stable at 5.0
Bear Case $20.05 (-31%)
Severe decline -20.0%, PE contracts to 4.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CARE Analysis

Share this live CARE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CARE)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish financial analyst on StockTwits expresses strong optimism towards $CARE, highlighting exceptional EPS growth over the last three quarters.
Key Retail Themes: Exceptional EPS growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CARE.

Create Free Account

Already have an account? Log In

Top Rated Banks - Regional Stocks

Top-rated stocks in Banks - Regional by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
USB
U.S. Bancorp
BUY
24 analysts
$69 56 HOLD
PNFP
Pinnacle Financial Partnâ€Ļ
STRONG BUY
22 analysts
$121 50 HOLD
HBAN
Huntington Bancshares Inâ€Ļ
BUY
21 analysts
$19 47 HOLD
FLG
Flagstar Bank, National â€Ļ
BUY
18 analysts
$13 59 HOLD
SSB
SouthState Corporation
STRONG BUY
14 analysts
$120 52 HOLD

Advanced CARE Option Strategies

Professional options setups generated by AI based on today's CARE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CARE Research Pages
CARE Technical Chart CARE Price Prediction CARE Intrinsic Value DCF CARE Earnings Date CARE Investment Advisor CARE Fair Price Analyzer CARE Options Chain CARE Options Advisor CARE Options Analysis CARE Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals